Editorial: From Trial and Error to Individualised Pharmacogenomics-Based Pharmacotherapy in Psychiatry

Editorial: From Trial and Error to Individualised Pharmacogenomics-Based Pharmacotherapy in Psychiatry

Bibliographic Details
Main Authors:	R. van Westrhenen, M. Ingelman-Sundberg
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Pharmacology
Subjects:	pharmacogenomics psychiatry psychopharmacology CYP enzymes side effects
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.725565/full

Similar Items

Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?
by: Roos van Westrhenen, et al.
Published: (2020-03-01)

Pharmacogenomics and the Management of Mood Disorders—A Review
by: Kristian Kleine Schaars, et al.
Published: (2023-07-01)

The Three Ps: Psychiatry, Pharmacy, and Pharmacogenomics, a Brief Report From New Zealand
by: Simran D.S. Maggo, et al.
Published: (2019-09-01)

Pharmacogenomic Biomarkers and Their Applications in Psychiatry
by: Heejin Kam, et al.
Published: (2020-11-01)

A New Intervention for Implementation of Pharmacogenetics in Psychiatry: A Description of the PSY-PGx Clinical Study
by: Teuntje A. D. Pelgrim, et al.
Published: (2024-01-01)

Optimizing drug selection in psychopharmacology based on 40 significant CYP2C19- and CYP2D6-biased adverse drug reactions of selective serotonin reuptake inhibitors
by: Andy R. Eugene
Published: (2019-10-01)

Policy and Practice Review: A First Guideline on the Use of Pharmacogenetics in Clinical Psychiatric Practice
by: R. van Westrhenen, et al.
Published: (2021-04-01)

Pharmacogenomics: introduction and use in clinical practice
by: Saunders Hollie, et al.
Published: (2020-06-01)

Pharmacogenetics in Psychiatry: An Update on Clinical Usability
by: Ron H. N. van Schaik, et al.
Published: (2020-09-01)

Pharmacotherapy of child and adolescent psychiatric disorders /
by: Rosenberg, David R., et al.
Published: (2012)

Validating an implicit cognition battery in Parkinson’s disease and assessing its sensitivity to pharmacological manipulation
by: Nahon, S
Published: (2019)

Pharmacogenomics of Old and New Immunosuppressive Drugs for Precision Medicine in Kidney Transplantation
by: Stefano Turolo, et al.
Published: (2023-07-01)

Pharmacogenomic Testing and Patient Perception Inform Pain Pharmacotherapy
by: Feng-Hua Loh, et al.
Published: (2021-10-01)

Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in Psychopharmacology
by: Hervé Javelot, et al.
Published: (2021-08-01)

Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants
by: Antón Álvarez, et al.
Published: (2010-09-01)

Drug treatment in psychiatry /
by: Turner, Paul
Published: (1974)

Editorial: Population Pharmacogenomics (PGx): From Variant Identification to Clinical Implementation
by: Masahiro Hiratsuka, et al.
Published: (2021-08-01)

Analyses of Pharmacokinetic, Pharmacogenetic and Psychometrics Correlates of Antidepressants Use during Pregnancy and the Post-Partum Period
by: R. Cafaro, et al.
Published: (2022-06-01)

Psychiatric clinical profiles and pharmacological interactions in COVID-19 inpatients referred to a consultation liaison psychiatry unit
by: N. Arbelo, et al.
Published: (2021-04-01)

Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting
by: Sam Mostafa, et al.
Published: (2021-08-01)

The effects of losartan and diazepam on emotional processing
by: Thoroddsen, TA
Published: (2021)

The role of the 5-HT2C receptor in emotional processing in healthy adults
by: Rawlings, N
Published: (2010)

Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network
by: Duong BQ, et al.
Published: (2020-07-01)

The Road so Far in Colorectal Cancer Pharmacogenomics: Are We Closer to Individualised Treatment?
by: Ana Rita Simões, et al.
Published: (2020-11-01)

¿Do we prescribe less clozapine to immigrant psychotic patients compared to non-immigrant psychotic patients?
by: A. Trabsa, et al.
Published: (2022-06-01)

Pharmacogenomics in Psychiatry Practice: The Value and the Challenges
by: Aminah Alchakee, et al.
Published: (2022-11-01)

Editorial: Precision psychiatry from a pharmacogenetics perspective
by: Lisa C. Brown, et al.
Published: (2023-03-01)

Pharmacogenomic testing: aiding in the management of psychotropic therapy for adolescents with autism spectrum disorders
by: Bose-Brill S, et al.
Published: (2017-09-01)

Pharmacogenomics of CYP2C9: Functional and Clinical Considerations
by: Ann K. Daly, et al.
Published: (2017-12-01)

Pharmacogenomics in drug discovery and development /
by: Yan, Qing, 1971-
Published: (2008)

User Experiences of Pharmacogenomic Testing and Opinions among Psychiatry Patients
by: Catherine R. Virelli, et al.
Published: (2023-12-01)

Editorial: Brief research reports in pharmacogenetics and pharmacogenomics: 2022
by: Francesco Sessa, et al.
Published: (2023-03-01)

Use of combinatorial pharmacogenomic testing in two cases from community psychiatry
by: Fields ES, et al.
Published: (2016-08-01)

Antihypertensives associated adverse events: a review of mechanisms and pharmacogenomic biomarkers available evidence in multi-ethnic populations
by: Sahar M. Altoum, et al.
Published: (2023-12-01)

Public Attitudes toward Pharmacogenomic Testing and Establishing a Statewide Pharmacogenomics Database in the State of Minnesota
by: Lusi Zhang, et al.
Published: (2022-09-01)

Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications
by: Tanner JA, et al.
Published: (2019-12-01)

Towards a neurocognitive understanding of angiotensin-II receptor blockade: insights into memory, stress, and their implications for PTSD
by: Shkreli, L
Published: (2024)

Population Pharmacogenomics in Croatia: Evaluating the PGx Allele Frequency and the Impact of Treatment Efficiency
by: Vid Matišić, et al.
Published: (2023-08-01)

Pharmacogenomics (PGx) Patient with Mixed Levels of Actionable Variant Evidence
by: Michael J. Schuh, et al.
Published: (2020-05-01)

INTEGRATING PHARMACOGENOMICS INTO CLINICAL PRACTICE
by: Gurinder Johal, et al.
Published: (2016-05-01)